This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Wealth Building Routines For Success
Create wealth building routines that foster financial success. These consistent practices can lead to significant wealth accumulation over time.
12,178 articles
This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Redwire Contract Success Story Sparks Debate Ahead of Dip
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Wall Street Expects This Growth Stock to Double Soon
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Bristol Myers Squibb Johnson: Which Stock to Buy in 2026?
Choosing between two healthcare giants comes down to balance: steady income or longer-term growth. This guide dives i...
Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Finassets Raises Affiliate Revenue, Tops Crypto Payouts
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
Structure Therapeutics Stock 187% Gains: What It Means
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status